Evonik
Leading Beyond Chemistry
Company Presentation Q2 2021
Key messages Q2 2021
Strong Q2 and sustained positive dynamic into H2 driving outlook uplift
Strong Q2 performance with adj. EBITDA of €649 m clearly above pre-pandemic level (+15% vs Q2 2019)
"Specialty growth": Growth divisions with 18% higher adj. EBITDA vs. Q2 2019
Structural growth drivers well intact across all three growth divisions - sustainability as common theme
Continued strong cash generation: On track to extend 40% cash conversion track record also in FY 2021
Sustained positive dynamic into H2 - raw material price impact balancing out across the portfolio
FY 2021 adj. EBITDA outlook raised to €2.3 to 2.4 bn - likely ending up in upper part of range
2 | August / September 2021 | Evonik Q2 2021 Company Presentation
Table of contents
- Evonik at a glance
- Strategy
- Financials Q2 2021
- Appendix
3 | August / September 2021 | Evonik Q2 2021 Company Presentation
LEADING BEYOND CHEMISTRY
TO IMPROVE LIFE, TODAY AND TOMORROW
4 | August / September 2021 | Evonik Q2 2021 Company Presentation
Leading Beyond Chemistry - Our purpose
Evonik on the way to become a best-in-class specialty chemicals company
Video "We are Evonik"
Leading …
… Beyond …
… Chemistry
- Leading market positions in 80% of our business
- Leading key financial indicators
- Connecting skills and perspectives
- Develop solutions together with partners
- Sustainability key driver of growth
- Clear focus on specialty chemicals
- Target 100% specialty portfolio
5 | August / September 2021 | Evonik Q2 2021 Company Presentation
This is an excerpt of the original content. To continue reading it, access the original document here.
Attachments
- Original document
- Permalink
Disclaimer
Evonik Industries AG published this content on 13 September 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 13 September 2021 05:51:00 UTC.